Back to search

Article

Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis

2020-12-07

Abstract excerpt

<h4>Background</h4> Antipsychotics suppress expression of inflammatory cytokines and inducible inflammatory enzymes. Elopiprazole (a phenylpiperazine antipsychotic drug in phase 1) has been characterized as a therapeutic drug to treat SARS-CoV-2 infection in a repurposing study. We aim to investigate the potential effects of aripiprazole (an FDA approved phenylpiperazine) on COVID19-related immunological parameter...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8396326-b3c6-50af-ac97-b4a3f74466b6
DOI
10.1101/2020.12.05.20244590
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysisDOI 10.1101/2020.12.05.20244590
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic AnalysisSemantic proximity
COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disordersSemantic proximity
Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine ApproachSemantic proximity
Discovery and Identification of Candidate Genes, Diagnostic Model and Drug Predictions for Schizophrenia and Crohn's Disease Through Integrated Bioinformatics Analysis and Machine LearningSemantic proximity
Genetic analyses point to alterations in immune-related pathways underpinning the association between psychiatric disorders and COVID-19Semantic proximity
Associations between brain gene expression perturbations implicated by COVID-19 and psychiatric disorders.Semantic proximity
Transcriptomic analysis uncovers the shared and unique biological foundations acrossSchizophrenia, Bipolar and Major Depressive DisordersSemantic proximity
Innate immune response is differentially dysregulated between bipolar disease and schizophreniaSemantic proximity
A transcriptome-wide Mendelian randomization study in isolated human immune cells highlights risk genes involved in viral infections and potential drug repurposing opportunities for schizophreniaSemantic proximity
A Transcriptome-Wide Mendelian Randomization Study in Isolated Human Immune Cells Highlights Risk Genes Involved in Viral Infections and Potential Drug Repurposing Opportunities for Schizophrenia.Semantic proximity
A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysisSemantic proximity
Select a neighboring publication to make it the new centre.